Plan Sponsor Contribution Limits

Plan Sponsor Contribution Limits refer to the maximum amount that an employer can contribute to their employees' 401(k) retirement plans. These limits are set by the Internal Revenue Service (IRS) and serve as guidelines to ensure fairness and adherence to tax regulations within the context of employer-sponsored retirement plans.

Examples:

  • Annual Matching Contributions: One common form of employer contribution is a matching contribution. For instance, a company may match an employee's 401(k) contributions up to a certain percentage of their salary, such as 50% of the first 6% of the employee's salary contributed to the plan. If the IRS sets a Plan Sponsor Contribution Limit of $10,000, the employer can't contribute more than this amount as a match for any individual employee in a given year.
  • Profit-Sharing Contributions: Some employers offer profit-sharing contributions to their employees' 401(k) plans based on the company's financial performance. If the company decides to contribute a fixed percentage of its profits to employees' retirement accounts, the Plan Sponsor Contribution Limits dictate the maximum amount the employer can contribute per employee.
  • Non-Discrimination Testing Compliance: To ensure that 401(k) plans are not unfairly favoring highly compensated employees, the IRS imposes non-discrimination testing requirements. These tests assess the proportion of contributions made by highly compensated employees relative to lower-paid staff. If the employer exceeds the Plan Sponsor Contribution Limits, they risk failing the non-discrimination tests, leading to potential tax implications and corrective measures. Hence, adhering to these limits is crucial for maintaining compliance with IRS regulations.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.